Motley Rice
@motleyrice.bsky.social
We litigate cutting-edge and complex cases, give back to our profession and our communities, and believe that just one person can bring about change.
motleyrice.com/disclaimer
motleyrice.com/disclaimer
As Ron Motley said when we first filed these cases: “we’ll leave no stone unturned.” We remain committed to his beliefs and our clients as we pursue civil justice for the victims and families of September 11.
Learn more:
Learn more:
9/11 families urge president to force Saudi prince to accept blame for attacks
Loved ones of 9/11 victims are urging the Trump administration to compel Saudi Arabia to “ensure accountability” with a federal lawsuit against the Kingdom.
www.bostonherald.com
November 18, 2025 at 6:42 PM
As Ron Motley said when we first filed these cases: “we’ll leave no stone unturned.” We remain committed to his beliefs and our clients as we pursue civil justice for the victims and families of September 11.
Learn more:
Learn more:
The thousands of family members ask the U.S. to have an honest conversation with Saudi Crown Prince Mohammed bin Salman about the role of Saudi government actors in the 9/11 Attacks and to require the Kingdom to account for that role.
November 18, 2025 at 6:42 PM
The thousands of family members ask the U.S. to have an honest conversation with Saudi Crown Prince Mohammed bin Salman about the role of Saudi government actors in the 9/11 Attacks and to require the Kingdom to account for that role.
- Motley Rice attorney Jonathan Orent, co-lead counsel and a member of the Plaintiffs' Executive Committee (PEC) for MDL against Novo Nordisk and Eli Lilly, makers of diabetes and weight loss drugs including Ozempic®, Wegovy®, Mounjaro® and other GLP-1 RA medications.
September 18, 2025 at 3:38 PM
- Motley Rice attorney Jonathan Orent, co-lead counsel and a member of the Plaintiffs' Executive Committee (PEC) for MDL against Novo Nordisk and Eli Lilly, makers of diabetes and weight loss drugs including Ozempic®, Wegovy®, Mounjaro® and other GLP-1 RA medications.
"Drugmakers like Novo Nordisk and Eli Lilly must be held accountable for downplaying dangers in ads that are arguably deceptive and misleading. We no longer have to wait for a legal reckoning for drugmakers that aren’t fully transparent — it’s here.”
September 18, 2025 at 3:38 PM
"Drugmakers like Novo Nordisk and Eli Lilly must be held accountable for downplaying dangers in ads that are arguably deceptive and misleading. We no longer have to wait for a legal reckoning for drugmakers that aren’t fully transparent — it’s here.”
At Motley Rice, we remain committed to seeking justice and holding Big Tech companies, like Meta, accountable for alleged harmful conduct.
Learn more:
Learn more:
Meta covered up potential child harms, whistleblowers claim
Meta denies the allegations and described the "claims at the heart" of the Senate hearing as "nonsense".
www.bbc.com
September 16, 2025 at 5:48 PM
At Motley Rice, we remain committed to seeking justice and holding Big Tech companies, like Meta, accountable for alleged harmful conduct.
Learn more:
Learn more:
“This ruling out of the federal court in Manhattan marks a significant achievement for the families of victims”, says Motley Rice attorney Don Migliori.
Learn more via @usatoday.com
Learn more via @usatoday.com
9/11 families say this US ally helped the hijackers. They're suing to know the truth.
A federal judge in New York denied a motion from Saudi Arabia to dismiss a lawsuit over the Gulf state’s potential involvement in the attacks.
www.usatoday.com
September 11, 2025 at 6:03 PM
“This ruling out of the federal court in Manhattan marks a significant achievement for the families of victims”, says Motley Rice attorney Don Migliori.
Learn more via @usatoday.com
Learn more via @usatoday.com
Our client, Todd Engel shares his story in hopes of raising awareness of the potential risk for sudden blindness when using semaglutides:
Sudden blindness possible rare side effect of popular diabetes & weight loss drugs
A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side effect they were never warned abou
thenationaldesk.com
August 29, 2025 at 5:05 PM
Our client, Todd Engel shares his story in hopes of raising awareness of the potential risk for sudden blindness when using semaglutides:
[...] and noted that a public trial will determine the rest." - MDL co-lead and Motley Rice attorneys Jodi Westbrook Flowers and Donald Migliori
Judge allows families of 9/11 victims to sue Saudi Arabia for allegedly helping hijackers
A federal judge in New York kept alive a lawsuit accusing officials in Saudi Arabia of assisting the Sept. 11 hijackers — which the Saudi government has vehemently denied.
www.cbsnews.com
August 29, 2025 at 12:26 AM
[...] and noted that a public trial will determine the rest." - MDL co-lead and Motley Rice attorneys Jodi Westbrook Flowers and Donald Migliori
"The court concluded “the total evidence creates a high probability as to Bayoumi and Thumairy’s roles in the hijacker’s plans, and the related role of their employer [Saudi Arabia]” [...]
August 29, 2025 at 12:26 AM
"The court concluded “the total evidence creates a high probability as to Bayoumi and Thumairy’s roles in the hijacker’s plans, and the related role of their employer [Saudi Arabia]” [...]
Jonathan appeared on Spotlight America to discuss the growing concerns over potentially serious side effects of specific weight loss prescription medicines: ktvl.com/news/spotlig...
Serious side-effects for popular weight loss drugs raising concerns
Weight loss drugs are exploding in popularity across the country with many calling them game-changers when it comes to treating obesity and all the medical cond
ktvl.com
August 20, 2025 at 8:45 PM
Jonathan appeared on Spotlight America to discuss the growing concerns over potentially serious side effects of specific weight loss prescription medicines: ktvl.com/news/spotlig...
We are proud of our clients for bravely sharing their stories to help raise awareness of health risks they claim are from chemical hair relaxers.
Learn more about these victims and the ongoing litigation:
Learn more about these victims and the ongoing litigation:
Over 10,000 Women Now Allege That Toxic Chemicals in Hair Relaxers Gave Them Cancer - Consumer Reports
Three women tell their stories about their experiences using relaxers, and what their diagnoses have meant for their and their families' lives.
www.consumerreports.org
July 22, 2025 at 2:50 PM
We are proud of our clients for bravely sharing their stories to help raise awareness of health risks they claim are from chemical hair relaxers.
Learn more about these victims and the ongoing litigation:
Learn more about these victims and the ongoing litigation:
Learn more about the latest developments:
'A Daft Suggestion': Judge Declines to Kick Hundreds of Paraquat Cases Out of Philadelphia | Law.com
Judge Joshua Roberts of the Philadelphia Court of Common Pleas on July 11 denied a motion from Syngenta Crop Protection LLC and Chevron U.S.A. Inc. that challenged the plaintiffs’ choice of forum in P...
www.law.com
July 18, 2025 at 5:38 PM
Learn more about the latest developments:
Watch the full interview here:
Boeing 787 software may have caused AI crash: Aviation expert - The Sunday Guardian Live
Mary Schiavo warns Air India crash may involve Boeing 787’s software-triggered engine thrust rollback malfunction. NEW DELHI: In a wide-ranging exclusive
sundayguardianlive.com
July 2, 2025 at 7:13 PM
Watch the full interview here:
"The investigators need to carefully review the aircraft maintenance and repair records, thoroughly examine what the NTSB 787 investigation revealed, investigate what data and records they had from Boeing, and equally important, explore what they didn't previously receive or review from Boeing.”
July 2, 2025 at 7:13 PM
"The investigators need to carefully review the aircraft maintenance and repair records, thoroughly examine what the NTSB 787 investigation revealed, investigate what data and records they had from Boeing, and equally important, explore what they didn't previously receive or review from Boeing.”